Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Feb 22;170(1):101–109. doi: 10.1007/s10549-018-4727-9

Table 3.

The 5-year (60-month) overall survival probabilities (Pr) for the neoadjuvant patients

Measure Pr (T > 60) 95% CI
Pathological complete response 0.964 0.915–1.000
No pathological complete response 0.798 0.686–0.927